Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000443723 | SCV000521558 | likely benign | not provided | 2020-10-29 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20849526) |
Fulgent Genetics, |
RCV000763942 | SCV000894888 | uncertain significance | Methylmalonic acidemia with homocystinuria, type cblJ | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000763942 | SCV001113750 | likely benign | Methylmalonic acidemia with homocystinuria, type cblJ | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000763942 | SCV001139484 | likely benign | Methylmalonic acidemia with homocystinuria, type cblJ | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000443723 | SCV001371596 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | ABCD4: PP3, BS2 |
Mayo Clinic Laboratories, |
RCV000443723 | SCV004227328 | uncertain significance | not provided | 2023-01-06 | criteria provided, single submitter | clinical testing | BS1, PP3 |
Prevention |
RCV004758013 | SCV005344407 | likely benign | ABCD4-related disorder | 2024-07-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |